{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:26:59Z","timestamp":1771648019465,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Graves\u2019 orbitopathy (GO) is an autoimmune orbital disorder characterized by chronic inflammation and aberrant extracellular matrix (ECM) remodeling, leading to progressive fibrosis. Recent studies implicate matrix metalloproteinase\u221214 (MMP14) in ECM degradation and tissue remodeling, yet its precise role in GO remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and methods<\/jats:title><jats:p>Orbital adipose\/connective tissues specimens were obtained from GO patients (stratified into type I and type II based on clinical classification) and non\u2212GO controls. High\u2212throughput RNA sequencing identified differentially expressed genes, focusing on MMP\u2212related transcripts. MMP14 expression was quantified by immunohistochemistry and Western blotting, correlating its levels with fibrotic grade. Primary orbital fibroblasts (OFs) isolated from GO and control subjects were cultured and stimulated with TGF\u2212\u03b21. Quantitative real\u2212time PCR and Western blot assays evaluated MMP14 and fibroblast activation markers (\u03b1\u2212SMA, COL1A1, CTGF). Transcriptomic profiling of TGF\u2212\u03b21\u2013treated OFs and a scratch wound assay further assessed the effect of the MMP14 inhibitor NSC\u2212405020 on cellular motility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>GO type II tissues demonstrated a significant upregulation of MMP14, which correlated positively with fibrosis severity. GO\u2212 derived OFs exhibited higher basal and TGF\u2212\u03b21\u2013induced MMP14 and fibrotic marker expression compared to controls. Transcriptomic analysis revealed activation of ECM\u2013receptor interaction, PI3K\u2212Akt, and MAPK signaling pathways enriched for MMP\u2212associated genes. Pharmacologic inhibition of MMP14 attenuated TGF\u2212\u03b21\u2013induced fibrotic markers and reduced OFs migration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings indicate that MMP14 is a central mediator in GO fibrotic remodeling, highlighting its potential as a therapeutic target to alleviate orbital fibrosis. Further mechanistic studies are needed to clarify MMP14\u2019s role in GO progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1623842","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:10:30Z","timestamp":1753157430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["MMP14 as a central mediator of TGF-\u03b21\u2212induced extracellular matrix remodeling in graves\u2019 orbitopathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinxin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of graves\u2019 Orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2014.937877","article-title":"Cytokine profiles in clinical subtypes of ophthalmic Graves\u2019 disease","volume":"33","author":"Linquist","year":"2014","journal-title":"Orbit"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/thy.1992.2.89","article-title":"Retroocular fibroblasts: important effector cells in Graves\u2019 ophthalmopathy","volume":"2","author":"Bahn","year":"1992","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"107502","DOI":"10.1016\/j.pharmthera.2020.107502","article-title":"TSH\/IGF1 receptor crosstalk: Mechanism and clinical implications","volume":"209","author":"Krieger","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2443","article-title":"Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a\u00a0potential treatment for Graves\u2019 ophthalmopathy","volume":"50","author":"van Steensel","year":"2009","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B8","article-title":"The protective effect of antioxidants on orbital fibroblasts from patients with Graves\u2019 ophthalmopathy in response to oxidative stress","volume":"19","author":"Tsai","year":"2013","journal-title":"Mol Vision"},{"key":"B9","doi-asserted-by":"publisher","first-page":"412158","DOI":"10.1155\/2014\/412158","article-title":"Markers of inflammation and fibrosis in the orbital fat\/connective tissue of patients with Graves\u2019 orbitopathy: clinical implications","volume":"2014","author":"Pawlowski","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00166.2024","article-title":"Interaction of MMP-9 in the active phase of Graves\u2019 disease with and without ophthalmopathy","volume":"327","author":"Riguetto","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20684","article-title":"Sphingosine-1-phosphate mediates fibrosis in orbital fibroblasts in graves\u2019 Orbitopathy","volume":"58","author":"Ko","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1038\/s41598-020-65414-1","article-title":"The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts","volume":"10","author":"Roztocil","year":"2020","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20065","article-title":"MT1-MMP: a tethered collagenase","volume":"200","author":"Holmbeck","year":"2004","journal-title":"J Cell Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10555-006-7891-z","article-title":"MT1-MMP: universal or particular player in angiogenesis","volume":"25","author":"Genis","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 european thyroid association\/european group on graves\u2019 Orbitopathy guidelines for the management of graves\u2019 Orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.17219\/acem\/68991","article-title":"Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves\u2019 orbitopathy","volume":"27","author":"Kapelko-Slowik","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"107962","DOI":"10.1016\/j.exer.2020.107962","article-title":"Integrative transcriptomics and proteomic analysis of extraocular muscles from patients with thyroid-associated ophthalmopathy","volume":"193","author":"Wu","year":"2020","journal-title":"Exp Eye Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.actbio.2017.02.041","article-title":"Generating favorable growth factor and protease release profiles to enable extracellular matrix accumulation within an in vitro tissue engineering environment","volume":"54","author":"Zhang","year":"2017","journal-title":"Acta Biomater"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.05.086","article-title":"Matrix metalloproteinase-14 is a mechanically regulated activator of secreted MMPs and invasion","volume":"450","author":"Haage","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40164-025-00635-6","article-title":"MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK\/STAT pathway","volume":"14","author":"Wu","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i19.2961","article-title":"MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration","volume":"29","author":"Wu","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57920","article-title":"Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP\/TGFbeta1 after myocardial infarction","volume":"9","author":"Alonso-Herranz","year":"2020","journal-title":"Elife"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01520","article-title":"Matrix metallopeptidase 14: A candidate prognostic biomarker for diffuse large B-cell lymphoma","volume":"10","author":"Yin","year":"2020","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207205200","article-title":"Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis","volume":"277","author":"Karsdal","year":"2002","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4421","article-title":"Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1","volume":"66","author":"Ottaviano","year":"2006","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01626","article-title":"Insights into local orbital immunity: evidence for the involvement of the th17 cell pathway in thyroid-associated ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.theriogenology.2018.10.005","article-title":"Effect of transforming growth factor -beta1 on alpha-smooth muscle actin and collagen expression in equine endometrial fibroblasts","volume":"124","author":"Szostek-Mioduchowska","year":"2019","journal-title":"Theriogenology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ijms23010146","article-title":"Matrix metalloproteinases shape the tumor microenvironment in cancer progression","volume":"23","author":"Niland","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1095\/biolreprod.113.114876","article-title":"Leptin-promoted human extravillous trophoblast invasion is MMP14 dependent and requires the cross talk between Notch1 and PI3K\/Akt signaling","volume":"90","author":"Wang","year":"2014","journal-title":"Biol Reprod"},{"key":"B34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/IGC.0b013e3181a83749","article-title":"Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K\/AKT and MAPK\/ERK pathways","volume":"19","author":"Zhang","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1242\/dev.084236","article-title":"Transmembrane\/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin beta1","volume":"140","author":"Mori","year":"2013","journal-title":"Development"},{"key":"B36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/art.42973","article-title":"Targeting CD13\/aminopeptidase N as a novel therapeutic approach for scleroderma fibrosis","volume":"77","author":"Muraoka","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cardiores.2004.03.010","article-title":"Regulation of matrix metalloproteinase MT1-MMP\/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase","volume":"63","author":"Stawowy","year":"2004","journal-title":"Cardiovasc Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21675","article-title":"MMP-14 mediated MMP-9 expression is involved in TGF-beta1-induced keratinocyte migration","volume":"104","author":"Seomun","year":"2008","journal-title":"J Cell Biochem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1623842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:10:32Z","timestamp":1753157432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1623842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":38,"alternative-id":["10.3389\/fendo.2025.1623842"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1623842","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"article-number":"1623842"}}